tirzepatide adolescent obesity trial for maintenance of bodyweight reduction in people with in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled Efficacy and safety of tirzepatide

Patients with certain genetic profiles may respond better to semaglutide alone, while others benefit from PlexusDx dual-compound protocols like GLP-Squared Injection (semaglutide plus tirzepatide)

The four-week intervals between dose adjustments align with the medication's pharmacokinetic profile, as steady-state concentrations are achieved after approximately four weeks of consistent dosing

503A compounders must operate under state pharmacy board oversight and are subject to regular inspections

In US, Ozempic and Humira combined sales surpassed the sales of all the generics (1,106 molecules) in 2023

GLP-1s are injectable medications that mimic natural hormones in the body to regulate digestion and appetite